ASCO 2018: Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
7 Jun, 2018 | 02:47h | UTCEditorial: Endocrine Adjuvant Therapy for Localized Breast Cancer (free)
Commentary: Aromatase Inhibitor Plus Ovarian Suppression Yields Benefit in High-Risk Premenopausal Patients With Breast Cancer – The ASCO Post (free)